The European Pain Federation EFIC® and the pharmaceutical company Grünenthal have announced the three recipients of the EFIC-Grünenthal Grant (E-G-G). With a total value of €100,000, this biennial grant rewards innovative projects for human pain research and supports...
As part of Europe’s Beating Cancer Plan, the smartCARE project is developing a Smart Card that empowers cancer survivors in Europe. The Smart Card, which will predominantly take the form of a mobile application, will be available all over Europe to allow...
The EFIC Education Committee are examining the provision of compulsory pain education and availability of postgraduate pain specialisation options for physicians, physiotherapists, nurses, and psychologists across Europe. This study is an update and extension of the...
The new EAN-EFIC-NeuPSIG guidelines on the Neuropathic Pain Assessment are out now! Read these evidence-based recommendations for the use of screening questionnaires and diagnostic tests in patients with neuropathic pain. Find out more below. Background...
Multimodal treatment is often recommended for many pain conditions. Despite this, the concept of multimodal treatment remains subject to different interpretations, with no consented definition, and a lack of agreement on the discrete modalities that comprise such...
At the beginning of 2023, EFIC kicked off the work on our pain research strategy working with a multidisciplinary steering committee. The pain strategy will serve as a foundation stone for European pain research plans for years to come. The overall vision will be to...